| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/16/2001 | EP1123090A1 Method and composition for modulating amyloidosis |
| 08/16/2001 | EP1123087A1 Oral pulsed dose drug delivery system |
| 08/16/2001 | EP1123086A2 Artificial antigen-specific cells and related methods |
| 08/16/2001 | EP1123085A1 O/w emulsion comprising an hydroxylated oil |
| 08/16/2001 | EP0891345B1 Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof |
| 08/16/2001 | EP0839137B1 Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use |
| 08/16/2001 | EP0688330B1 New o-sulfated gangliosides and lyso-ganglioside derivatives |
| 08/16/2001 | EP0628042B1 Serotoninergic ergoline derivatives |
| 08/16/2001 | DE10006139A1 Indol-3-yl-Derivate Indol-3-yl derivatives |
| 08/16/2001 | DE10004858A1 Verwendung von Proteinkinase-Inhibitor-alpha The use of protein kinase inhibitor alpha- |
| 08/16/2001 | CA2800450A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2736615A1 Method for classifying and treating physiologic brain imbalances using quantitative eeg |
| 08/16/2001 | CA2416343A1 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 08/16/2001 | CA2400472A1 Il-17 like molecules and uses thereof |
| 08/16/2001 | CA2400299A1 Dna encoding human vanilloid receptor vr3 |
| 08/16/2001 | CA2399939A1 Partners of ptb1 domain of fe65, preparation and uses |
| 08/16/2001 | CA2399799A1 2-phenylcarbamoyl-benzimidazoles |
| 08/16/2001 | CA2399623A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 08/16/2001 | CA2399593A1 Antibodies to ccr5 |
| 08/16/2001 | CA2399421A1 Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor |
| 08/16/2001 | CA2399396A1 Tnf- .alpha. inhibitors |
| 08/16/2001 | CA2399148A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2399136A1 1h-imidazopyridine derivatives |
| 08/16/2001 | CA2398956A1 A pharmaceutical composition for prophylaxis or therapy of a postoperative stress |
| 08/16/2001 | CA2398822A1 Piperazine and piperidine derivatives |
| 08/16/2001 | CA2398775A1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/16/2001 | CA2398567A1 Methods for enhancing the bioavailability of a drug |
| 08/16/2001 | CA2398282A1 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression |
| 08/16/2001 | CA2398136A1 Immunotherapy using interleukin 13 receptor subunit alpha 2 |
| 08/16/2001 | CA2397254A1 Interferon-alpha induced genes |
| 08/15/2001 | CN1308671A Myelin basic protein peptides and uses thereof |
| 08/15/2001 | CN1308632A 'Beta'-carboline compound |
| 08/15/2001 | CN1308617A Antiviral macrocyclic compounds |
| 08/15/2001 | CN1308616A Non-peptidyl inhibitors and VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory disease |
| 08/15/2001 | CN1308609A Method of locking 1 & alpha, -OH of vitamin d compounds in axial orientation |
| 08/15/2001 | CN1308606A Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use pharmaceutical preparations comprising them |
| 08/15/2001 | CN1308542A Sucoinamide inhibitors of interleukin-1& beta, converting enzyme |
| 08/15/2001 | CN1308536A Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 08/15/2001 | CN1308533A Agent with an antidepressive effect |
| 08/15/2001 | CN1308521A Novel formulation containing paroxetine |
| 08/15/2001 | CN1308492A Hypericin and i(hypericum) extract: specific T-type calcium channel blocker, and their use as T-type calcium channel targeted therapeutics |
| 08/15/2001 | CN1308069A Substittued (dihydro)benzoxazole and (dihydro)benzoxazine compound and their preparation and medicine composite |
| 08/15/2001 | CN1308059A Colchicine derivative and is treatment use |
| 08/15/2001 | CN1307889A Depression treating medicine and its preparation |
| 08/15/2001 | CN1307885A Vesania-treating medicine |
| 08/15/2001 | CN1307880A Depression treating medicine and its preparation |
| 08/15/2001 | CN1307878A Zhidaipian tablet for treating foolishness and its preparation |
| 08/15/2001 | CN1307869A Depression treating medicine |
| 08/15/2001 | CN1069635C Novel phenylalkylaminoalcohol carbamates and process for prepn. of same |
| 08/15/2001 | CN1069544C Thebaica giving-up vaccinum for man |
| 08/15/2001 | CN1069529C Pure traditional chinese medicine smoking giving up agent |
| 08/14/2001 | US6274768 Acridin derivatives |
| 08/14/2001 | US6274757 Neuromuscular relaxants |
| 08/14/2001 | US6274636 Method for treating a tic disorder |
| 08/14/2001 | US6274633 NMDA antagonist |
| 08/14/2001 | US6274624 Antiproliferative and neurotrophic molecules |
| 08/14/2001 | US6274623 Neuromuscular relaxants |
| 08/14/2001 | US6274618 Administering (-)-cis-6-phenyl-5-(4-(2-pyrrolidin-1-yl-ethoxy)-phenyl)-5,6,7,8 -tetrahydronphthalen-2-ol to treat vaginal dryness, itching, or painful intercourse |
| 08/14/2001 | US6274607 N-linked ureas and carbamates of heterocyclic thioesters |
| 08/14/2001 | US6274604 Alteration of circadian rhythmicity with a tachykinin antagonist |
| 08/14/2001 | US6274603 Administering probucol or an analog to treat alzheimer's disease |
| 08/14/2001 | US6274594 Isoquinoline derivatives and their therapeutical use |
| 08/14/2001 | US6274593 Treating psychological disorders, schizophrenia, and parkinson*s disease |
| 08/14/2001 | US6274588 4-phenyl-pyrimidine derivatives |
| 08/14/2001 | US6274579 Pharmaceutically active morpholinol |
| 08/14/2001 | US6274577 Autoimmune diseases; antiinflammatory agents |
| 08/14/2001 | US6274168 Phenytoin sodium pharmaceutical compositions |
| 08/14/2001 | CA2206824C Inhibitors of rotamase enzyme activity |
| 08/14/2001 | CA2193310C 4-imidazolidinone compounds; process for preparing the same and pharmaceutical compositions containing them |
| 08/14/2001 | CA2187591C Novel tertiary heterocyclic amines; process for preparing them and pharmaceutical compositions containing them |
| 08/14/2001 | CA2158484C Novel benzopyrane derivatives, process for their preparation and pharmaceutical compositions containing them |
| 08/14/2001 | CA2148380C 5-arylindole derivatives |
| 08/14/2001 | CA2124083C Preparation of substituted piperidines |
| 08/14/2001 | CA2029265C 4- and 6-carbamates related to physostigmine, a process and intermediates for their preparation and their use as medicaments |
| 08/10/2001 | CA2331876A1 Water-soluble ligand-binding proteins and analogs of ligand-gated channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
| 08/09/2001 | WO2001057267A1 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 08/09/2001 | WO2001057261A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | WO2001057240A2 Interaction of nmda receptor with protein tyrosine phosphatase |
| 08/09/2001 | WO2001057226A1 Humanized anti-ccr2 antibodies and methods of use therefor |
| 08/09/2001 | WO2001057175A2 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 08/09/2001 | WO2001057085A2 G-protein coupled receptors |
| 08/09/2001 | WO2001057078A1 Process for producing dialytic amyloid fiber polymerization nuclei, method of screening remedies for dialytic amyloidosis and remedies for dialytic amyloidosis |
| 08/09/2001 | WO2001057045A1 Novel positive allosteric ampa receptor modulators (paarm), method for the production and use thereof as medicaments |
| 08/09/2001 | WO2001057042A2 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 08/09/2001 | WO2001057039A1 Pyrrolo-isoquinoline and tetrahydropyrrolo-isoquinoline derivatives and their use as mediators of the 5-ht7 receptor |
| 08/09/2001 | WO2001057036A1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 08/09/2001 | WO2001057026A1 Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them |
| 08/09/2001 | WO2001057025A1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 08/09/2001 | WO2001057024A1 Blockade of voltage dependent sodium channels |
| 08/09/2001 | WO2001057023A1 Heterocyclic amide derivatives |
| 08/09/2001 | WO2001057022A2 Pyrazole compositions useful as inhibitors of erk |
| 08/09/2001 | WO2001057008A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors |
| 08/09/2001 | WO2001057002A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same |
| 08/09/2001 | WO2001056993A2 Pyrazole compositions useful as inhibitors of erk |
| 08/09/2001 | WO2001056992A2 Dibenzo (b,f) azepine intermediates |
| 08/09/2001 | WO2001056991A1 Substituted pyridine compounds useful for controlling chemical synaptic transmission |
| 08/09/2001 | WO2001056990A2 Pyridine derivates as potentiators of glutamate receptors |
| 08/09/2001 | WO2001056983A2 Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate |
| 08/09/2001 | WO2001056981A1 Use of vitamin d-derivatives in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivatives |
| 08/09/2001 | WO2001056598A2 Methods for preventing or attenuating pathoangiogenic conditions by using gbs-toxin (cm101) |